2/1/2019, 12:47 PM (Source: TeleTrader)
more TeleTrader news

Merck's sales rise 5% to $11B in Q4

Merck & Co. Inc. said on Friday that its earnings per share (EPS) in the fourth quarter of 2018 stood at $0.69, improving from a loss per share of $0.39 in the same period a year earlier. GAAP net income amounted to $1.8 billion, compared to a loss of $1 billion recorded a year earlier. Meanwhile, adjusted EPS rose 6% year on year to $1.04 and adjusted income amounted to $2.7 billion. Worldwide sales increased 5% compared to the fourth quarter of 2017 and were $11 billion.

For full fiscal 2018, the pharmaceutical giant's sales rose 5% to $42.3 billion. GAAP EPS and GAAP net income were $2.32 and $6.2 billion, respectively, while non-GAAP EPS stood at $4.34 and non-GAAP net income was $11.6 billion. "Last year was a strong one for Merck marked by substantial progress on scientific and commercial fronts," CEO Kenneth C. Frazier noted. "We enter 2019 with good momentum, anticipating the many opportunities afforded by our broad and differentiated portfolio and pipeline," he added.

Merck shares added 0.22% in premarket trading following the release of better-than-expected results.

Breaking the News / NP